查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲立体定位神经导航系统市场：分析与预测（2025-2035）
市场调查报告书
商品编码
1781116

欧洲立体定位神经导航系统市场：分析与预测（2025-2035）

Europe Stereotactic Neuro-Navigation System Market: Analysis and Forecast, 2025-2035
出版日期: | 出版商: BIS Research | 英文 63 Pages | 商品交期: 1-5个工作天内

价格

预计欧洲立体定位神经导航系统市场规模将从 2024 年的 2.69 亿美元成长到 2035 年的 10.142 亿美元，预测期内的复合年增长率为 13.14%。

欧洲立体定位神经导航产业持续保持两位数成长，这得益于神经系统疾病盛行率的不断上升，以及导航辅助手术相较于传统外科手术的显着优势。扩增实境(AR)、机器学习和人工智慧等技术的进步正在拓展这些平台的应用范围，并提高手术精度。微创手术的兴起进一步推动了对高精度导航技术的需求。此外，人口老化导致的与老龄化相关的神经系统疾病发生率上升也是推动市场扩张的另一个因素。

主要市场统计数据
预测期 2025-2035
2025年评估 2.95亿美元
2035年预测 10.142亿美元
复合年增长率 13.14%

先进导航系统高成本，难以与现有IT和影像系统集成，以及术中併发症的可能性，都可能成为其应用的障碍。然而，持续的技术创新、欧盟支持性法规结构（例如，简化的MDR途径）以及神经导航技术向脊椎和颅颜外科等相关领域的扩展，预计将推动市场保持成长势头，并在欧洲进一步扩张。

由于对微创手术和精准引导神经外科的需求不断增长，欧洲立体定位神经导航系统市场预计将大幅成长。这些系统在深部脑部刺激、肿瘤切片检查、功能性神经外科等领域正受到越来越多的关注，因为它们能够提供即时3D解剖映射和手术路径规划。此外，该地区人口老化以及癫痫、脑肿瘤和帕金森氏症等神经系统疾病盛行率的上升，促使医院投资先进的导航系统，以降低手术风险并改善患者预后。

技术创新也在推动市场扩张。扩增实境(AR) 迭加技术、人工智慧手术计划演算法以及与术中 MRI/CT 扫描仪的无缝集成，正在提高手术精度和工作流程效率。云端基础的个案管理和远距协作技术也日益普及，使得多家医疗机构共用专业知识，并加快术前准备。此外，西欧优惠的报销制度和东欧不断增长的医疗支出也推动了这些技术的采用。

然而，应用障碍依然存在。高昂的初始设置成本、软体许可费用、与现有影像诊断设备和医院IT系统的复杂集成，以及外科医生需要进行高级培训，这些都可能阻碍其广泛应用，尤其是在中小型区域性医院。此外，严格遵守欧盟医疗设备伙伴关係(MDR) 会增加时间和成本负担。展望未来，医疗设备製造商、学术机构和医疗机构之间持续的研发合作，以及系统间互通性的标准化努力，预计将进一步扩大临床应用范围，并推动市场稳步成长。

市场区隔:

细分一：按地区

  • 欧洲
    • 德国
    • 英国
    • 法国
    • 其他的

本报告调查了欧洲立体定位神经导航系统市场，并总结了主要趋势、市场影响因素分析、法律制度、技术和专利分析、市场规模趋势和预测、各个细分市场、地区/主要国家的详细分析、竞争格局和主要企业的概况。

目录

执行摘要

范围和定义

第一章市场：产业展望

  • 市场趋势
    • 利用协同效应效应实现业务组合多元化
  • 赎回情景
  • 监管状况/合规性
    • 欧洲
  • 供应链分析
  • 定价分析
  • 市场动态
    • 市场驱动因素
    • 市场限制
    • 市场机会

第 2 章：立体定位神经导航系统市场（按地区）

  • 欧洲
    • 区域概况
    • 市场成长动力
    • 市场问题
    • 英国
    • 德国
    • 法国
    • 其他的

第三章市场：竞争基准化分析与公司概况

  • 关键策略和发展
  • 产品基准
  • 市场占有率
  • 公司简介
    • Medtronic Plc
    • Brainlab AG
    • Elekta

第四章调查方法

This report can be delivered in 2 working days.

Introduction to Europe Stereotactic Neuro-Navigation System Market

The Europe stereotactic neuro-navigation system market is projected to reach $1,014.2 million by 2035 from $269.0 million in 2024, growing at a CAGR of 13.14% during the forecast period 2025-2035. The growing prevalence of neurological illnesses and the obvious benefits of navigation-assisted operations over traditional surgery have been driving double-digit growth in the stereotactic neuro-navigation industry in Europe. Advancements like augmented reality, machine learning, and artificial intelligence are expanding the use of these platforms and improving surgical accuracy. There is now a greater need for high-precision navigation technologies due to the move towards less intrusive procedures. Another factor supporting market expansion is an ageing population, which is contributing to an increase in age-related neurological diseases.

KEY MARKET STATISTICS
Forecast Period2025 - 2035
2025 Evaluation$295.0 Million
2035 Forecast$1,014.2 Million
CAGR13.14%

The high cost of sophisticated navigation systems, the difficulty of integrating them with current IT and imaging systems, and the possibility of intraoperative problems, however, can all be barriers to adoption. Notwithstanding these obstacles, continued technological advancements, pro-EU regulatory frameworks (such as streamlined MDR pathways), and the expansion of neuro-navigation into related specialities like spinal and craniofacial surgery are expected to maintain momentum and spur additional expansion throughout Europe.

Market Introduction

The market for stereotactic neuro-navigation systems in Europe is expected to develop significantly due to the rising demand for minimally invasive interventions and precision-guided neurosurgery procedures. These systems are becoming more and more popular for deep brain stimulation, tumour biopsies, epilepsy surgeries, and functional neurosurgery because they offer real-time, three-dimensional anatomical mapping and trajectory planning. Because of the region's ageing population and increased prevalence of neurological conditions including epilepsy, brain tumours, and Parkinson's disease, hospitals are investing in cutting-edge navigation systems that lower operating risks and enhance patient outcomes.

Technological advancements are driving market expansion: augmented reality overlays, AI-powered planning algorithms, and smooth integration with intraoperative MRI/CT scanners are improving surgical precision and workflow effectiveness. Cloud-based case management and remote collaboration technologies are also becoming more popular since they facilitate the sharing of expertise across many sites and expedite preoperative preparation. Adoption is also being aided by favourable reimbursement practices in Western Europe and rising healthcare spending in Eastern Europe.

Adoption obstacles still exist, though. Uptake may be slowed, particularly in smaller community hospitals, by high acquisition and software-licensing costs, complicated integration with legacy imaging and hospital IT systems, and the requirement for intensive surgeon training. Time and expense are increased by strict adherence to the EU Medical Device Regulation. In the future, it is anticipated that continued research and development partnerships among device makers, academic institutions, and healthcare providers-as well as initiatives to standardise interoperability-will expand clinical applications and propel steady expansion throughout the European stereotactic neuro-navigation market.

Market Segmentation:

Segmentation 1: by Region

  • Europe
    • Germany
    • U.K.
    • France
    • Rest-of-Europe

Europe Stereotactic Neuro-Navigation System Market Trends, Drivers and Challenges

Market Trends

  • Rising adoption of frameless, image-guided navigation systems offering enhanced ergonomics and workflow integration
  • Integration with intraoperative MRI/CT and augmented reality for real-time anatomical visualization
  • AI-driven planning tools that automate trajectory optimization and risk assessment
  • Cloud-based platforms enabling multi-site data sharing and remote surgical planning
  • Hybrid OR deployments combining neuro-navigation with robotics for end-to-end precision

Key Drivers

  • Growing incidence of brain tumors, movement disorders, and epilepsy fueling demand for precise surgical guidance
  • Shift toward minimally invasive neurosurgical techniques to reduce patient morbidity and hospitalization
  • Increased healthcare spending and favorable reimbursement policies across Western and Eastern Europe
  • Collaboration between device manufacturers and leading academic centers accelerating clinical validation
  • Need for streamlined workflows to boost OR efficiency and reduce procedure times

Major Challenges

  • High capital and recurring software-license costs limiting uptake in smaller hospitals
  • Complex integration with legacy imaging equipment and hospital IT systems
  • Steep learning curve for surgeons and OR staff requiring dedicated training programs
  • Evolving EU MDR requirements prolonging time to market and increasing compliance costs
  • Data-security and patient-privacy concerns around cloud-based case storage and analytics

Key Market Players and Competition Synopsis

The companies profiled have been selected based on inputs gathered from primary experts and an analysis of company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • Medtronic Plc
  • Brainlab AG
  • Elekta

Table of Contents

Executive Summary

Scope and Definition

1 Market: Industry Outlook

  • 1.1 Market Trends
    • 1.1.1 Leveraging Synergies to Diversify Business Portfolio
  • 1.2 Reimbursement Scenario
  • 1.3 Regulatory Landscape/Compliance
    • 1.3.1 Europe
      • 1.3.1.1 U.K.
  • 1.4 Supply Chain Analysis
  • 1.5 Pricing Analysis
  • 1.6 Market Dynamics
    • 1.6.1 Market Drivers
      • 1.6.1.1 Rising Prevalence of Neurological Disorders
      • 1.6.1.2 Benefits Offered by Navigation-Assisted Surgeries Over Conventional Surgeries
    • 1.6.2 Market Restraints
      • 1.6.2.1 Complications Associated with the Use of Navigation Systems
      • 1.6.2.2 High Cost of Acquisition
    • 1.6.3 Market Opportunities
      • 1.6.3.1 Integration of Artificial Intelligence (AI) and Machine Learning

2 Stereotactic Neuro-navigation System Market (By Region), $Million, 2023-2035

  • 2.1 Europe
    • 2.1.1 Regional Overview
    • 2.1.2 Driving Factors for Market Growth
    • 2.1.3 Factors Challenging the Market
    • 2.1.4 U.K.
    • 2.1.5 Germany
    • 2.1.6 France
    • 2.1.7 Rest of the Europe

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Key Strategies and Development
  • 3.2 Product Benchmarking
  • 3.3 Market Share
  • 3.4 Company Profiles
    • 3.4.1 Medtronic Plc
      • 3.4.1.1 Overview
      • 3.4.1.2 Top Products/Product Portfolio
      • 3.4.1.3 Top Competitors
      • 3.4.1.4 Target Customers
      • 3.4.1.5 Key Personal
      • 3.4.1.6 Analyst View
    • 3.4.2 Brainlab AG
      • 3.4.2.1 Overview
      • 3.4.2.2 Top Products/Product Portfolio
      • 3.4.2.3 Top Competitors
      • 3.4.2.4 Target Customers
      • 3.4.2.5 Key Personal
      • 3.4.2.6 Analyst View
    • 3.4.3 Elekta
      • 3.4.3.1 Overview
      • 3.4.3.2 Top Products/Product Portfolio
      • 3.4.3.3 Top Competitors
      • 3.4.3.4 Target Customers
      • 3.4.3.5 Key Personal
      • 3.4.3.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Europe Stereotactic Neuro-Navigation System Market (by Scenario), $Million, 2025, 2029, and 2035
  • Figure 2: Stereotactic Neuro-Navigation System Market, $Million, 2024 and 2035
  • Figure 3: EU Classification
  • Figure 4: NHS Classification
  • Figure 5: Supply Chain and Risks within the Supply Chain
  • Figure 6: Prevalence of Parkinson's Disease (by Region), 2016-2021
  • Figure 7: Increasing Incidence of CNS Brain Tumor Cases (by Region), 2022, 2025, 2035, and 2045
  • Figure 8: Increasing Aging Population Globally, Million, 2020-2023
  • Figure 9: Europe Stereotactic Neuro-Navigation Market, Spinal Navigation Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 10: Europe Stereotactic Neuro-Navigation Market, Cranial Stereotactic Surgery, Procedure Volume, Thousands, 2023-2035
  • Figure 11: Europe Stereotactic Neuro-Navigation Market, $Million, 2023-2035
  • Figure 12: Incidences of Neurological Disorders in U.K., Million, 2018-2021
  • Figure 13: U.K. Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 14: Incidences of Neurological Disorders in Germany, Million, 2018-2021
  • Figure 15: Germany Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 16: Incidences of Neurological Disorders in France, Million, 2018-2021
  • Figure 17: France Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 18: Incidences of Neurological Disorders in Rest-of-Europe, Million, 2018-2021
  • Figure 19: Rest-of-Europe Stereotactic Neuro-Navigation System Market, $Million, 2023-2035
  • Figure 20: Strategic Initiatives, January 2017-May 2025
  • Figure 21: Data Triangulation
  • Figure 22: Top-Down and Bottom-Up Approach
  • Figure 23: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Competitive Landscape Snapshot
  • Table 3: Some of the Key Developments
  • Table 4: CPT Coding
  • Table 5: Inpatient Reimbursement
  • Table 6: Price of Stereotactic Neuro-Navigation System
  • Table 7: Drivers, Restraints, and Opportunities: Current and Future Impact Assessment
  • Table 8: Comparison between Various Navigation-Assisted Surgeries Over Conventional Surgeries
  • Table 9: Sources of Error in Navigated Surgery
  • Table 10: Cost of Acquisition of Key Neuro-Navigation Systems
  • Table 11: Stereotactic Neuro-Navigation System Market (by Region), $Million, 2023-2035
  • Table 12: U.K. Incidences of Neurological Disorders, By Disease Type, 2018-2021
  • Table 13: Germany Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 14: France Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 15: Rest-of-Europe Incidences of Neurological Disorders, By Disease Type, 2018-2020
  • Table 16: Some of the Strategies and Development, January 2017-May 2025
  • Table 17: Europe Stereotactic Neuro-Navigation System Market, Product Benchmarking (by Product)
  • Table 18: Market Share Analysis, 2024